Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Antivenom Industry?

In recent periods, the antivenom market has seen robust growth. This market is projected to expand from $1.92 billion in 2024 to $2.04 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.4%. Factors influencing growth during the historic time include an elevated rate of snakebites, the geographic presence of venomous snakes, restricted access to healthcare facilities, activities in rural and agricultural sectors, and public health drives.

In the forthcoming years, the antivenom market is poised for robust growth, with its size anticipated to reach $2.69 billion in 2029 and a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecasted period can be ascribed to factors like climate change affecting snake habitats, growing populations in snake-infested areas, advancements in antivenom technology, worldwide health security initiatives, and coordinated actions for developing antivenom. During the estimated period, major trends likely to shape the market include the application of data analytics, emphasis on education and training, strategic collaborations to expand production, improvements in regulatory standards, and research into new therapeutic targets.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10798&type=smp

#Which Factors Are Currently Driving The Growth Of The Antivenom Market?

The antivenom market is anticipated to expand due to the increasing rise in snake bite incidences. Snake bites can result in a potentially deadly disease due to the toxic venom from the snake, and antivenom is a targeted treatment that can either prevent or eliminate most symptoms associated with snakebite poisoning if administered promptly in the correct therapeutic dosage. As revealed by the World Health Organization (WHO), a United Nations entity based in Switzerland responsible for public health, it’s estimated that in September 2023, about 5.4 million people worldwide are bitten by snakes annually. This leads to between 1.8 and 2.7 million envenoming cases. Each year, roughly 81,410 to 137,880 individuals lose their lives due to snake bites. The goal is to cut the mortality and disability rates linked to snakebite envenoming by 50% by the year 2030. Consequently, the escalating occurrence of snake bites contributes to the growth of the antivenom market.

How Is The Global Antivenom Market Structured In Terms Of Segments?

The antivenom market covered in this report is segmented –

1) By Type: Monovalent, Polyvalent, Other Types

2) By Animal: Snakes, Scorpions, Spiders, Other Animals

3) By Mode of Action: Cytotoxic, Neurotoxic, Hemotoxic, Cardiotoxic, Myotoxic, Other Modes Of Action

4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Monovalent: Specific Antivenoms For Individual Snake Species, Specific Antivenoms For Individual Venom Types

2) By Polyvalent: Broad-Spectrum Antivenoms, Regional Polyvalent Antivenoms

3) By Other Types: Antivenoms For Other Venoms, Recombinant Antivenoms, Antivenom For Rare Venoms

What Trends Are Currently Influencing Growth In The Antivenom Market?

Major players in the antivenom market are focused on developing cutting-edge technology, like public-benefit target products, to increase the effectiveness, safety, and accessibility of antivenoms in a bid to enhance patient outcomes and mitigate the global impact of snakebite poisonings. Public-benefit target products are health care innovations or medical solutions created mainly to meet the specific public health demands, particularly in neglected or vulnerable groups. For instance, in June 2023, the US-based biopharmaceutical firm, Bharat Serums and Vaccines Ltd., partnered with the Indian Institute of Science, an Indian public institution, to develop antivenoms specifically intended for snakebites in India. The partnership is set on improving the effectiveness of treatments and minimizing the public health consequences of snakebites in the affected areas.

Who Are The Main Participants Shaping The Antivenom Market Landscape?

Major companies operating in the antivenom market include Pfizer Inc., Commonwealth Serum Laboratories, Merck KGaA, Incepta Pharmaceuticals Limited, Bharat Serums and Vaccines Limited, Rare Disease Therapeutics Inc., Vins Bioproducts Limited, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Haffkine Bio-Pharmaceutical Corporation Limited, MicroPharm Limited, Latoxan SAS, Serum Institute of India Pvt. Ltd., BSV Group, Shanghai Serum Biotech Co Ltd., British Technology Group International, South African Vaccine Producers, Bioclon Institute, Inosan Biopharma, Instituto Bioclon S.A. de C.V., F. Hoffmann-La Roche AG, Protherics Inc., Sanofi Pasteur SA, Venom Supplies Pty Ltd, Instituto Clodomiro Picado, Laboratorios Silanes S.A. de C.V., Instituto Biológico Argentino S.A., Instituto Vital Brazil, Instituto Butantan, Instituto Nacional de Producción de Biológicos, Instituto de Biotecnología de la UNAM

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antivenom-global-market-report

Which Region Currently Holds The Largest Share In The Antivenom Market?

North America was the largest region in the global antivenom market size in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antivenom market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10798&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model